ANDREOTTI, GIUSEPPINA
ANDREOTTI, GIUSEPPINA
Istituto di Chimica Biomolecolare - ICB - Sede Pozzuoli
Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat
2024 Hay Mele, Bruno; Rossetti, Federica; Cubellis, Maria Vittoria; Monticelli, Maria; Andreotti, Giuseppina
Exploring ligand interactions with human phosphomannomutases using recombinant bacterial thermal shift assay and biochemical validation
2024 Monticelli, Maria; Hay Mele, Bruno; Wright, Demi Marie; Guerriero, Simone; Andreotti, Giuseppina; Cubellis, Maria Vittoria
ReBaTSA: A simplified CeTSA protocol for studying recombinant mutant proteins in bacterial extracts
2024 Monticelli, Maria; Wright, Demi Marie; Cubellis, Maria Vittoria; Andreotti, Giuseppina
Congenital disorders of glycosylation: narration of a story through its patents
2023 Monticelli, Maria; D'Onofrio, Tania; Jaeken, Jaak; Morava, Eva; Andreotti, Giuseppina; Vittoria Cubellis, Maria
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease
2023 Monticelli, Maria; Hay Mele, Bruno; Allocca, Mariateresa; Liguori, Ludovica; Lukas, Jan; Monti Maria, Chiara; Morretta, Elva; Cubellis Maria, Vittoria; Andreotti, Giuseppina
Enzyme Replacement Therapy for FABRY Disease: Possible Strategies to Improve Its Efficacy
2023 Iacobucci, Ilaria; Hay Mele, Bruno; Cozzolino, Flora; Monaco, Vittoria; Cimmaruta, Chiara; Monti, Maria; Andreotti, Giuseppina; Monticelli, Maria
Drug Repositioning for Fabry Disease:Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones
2022 Monticelli, M; Liguori, L; Allocca, M; Bosso, A; Andreotti, G; Lukas, J; Monti, Mc; Morretta, E; Cubellis, Mv; Mele, Bh
Evolutionary rescue of phosphomannomutase deficiency in yeast models of human disease
2022 C Vignogna, Ryan; Allocca, Mariateresa; Monticelli, Maria; W Norris, Joy; Steet, Richard; O Perlstein, Ethan; Andreotti, Giuseppina; I Lang, Gregory
Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)
2022 Brasil, Sandra; Allocca, Mariateresa; M Magrinho, Salvador C; Santos, Inês; Raposo, Madalena; Francisco, Rita; Pascoal, Carlota; Martins, Tiago; A Videira, Paula; Pereira, Florbela; Andreotti, Giuseppina; Jaeken, Jaak; A Kantautas, Kristin; O Perlstein, Ethan; dos Reis Ferreira, Vanessa
Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women
2021 Monticelli, M; Hay Mele, B; Benetti, E; Fallerini, C; Baldassarri, M; Furini, S; Frullanti, E; Mari, F; GENCOVID Multicenter, Study; Andreotti, G; Cubellis, Mv; Renieri, A
Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19
2021 Monticelli, M; Mele, Bh; Andreotti, G; Cubellis, Mv; Riccio, G
Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations
2020 Liguori, L; Monticelli, M; Allocca, M; Hay Mele, B; Lukas, J; Cubellis, Mv; Andreotti, G
Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypesin Fabry disease
2020 Seemann, Susanne; Ernst, Mathias; Cimmaruta, Chiara; Struckmann, Stephan; Cozma, Claudia; Koczan, Dirk; Knospe, Annemarie; R Haake, Linda; Citro, Valentina; U Bräuer, Anja; Andreotti, Giuseppina; V Cubellis, Maria; Fuellen, Georg; Hermann, Andreas; Giese, Annekatrin; Rolfs, Arndt; Lukas, Jan
Rational Design, Synthesis, Characterization and Evaluation of Iodinated 4,4'-Bipyridines as New Transthyretin Fibrillogenesis Inhibitors
2020 Dessì, Alessandro; Peluso, Paola; Dallocchio, Roberto; Weiss, Robin; Andreotti, Giuseppina; Allocca, Mariateresa; Aubert, Emmanuel; Pale, Patrick; Mamane, Victor; Cossu, Sergio
?-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG
2019 Monticelli, M; Liguori, L; Allocca, M; Andreotti, G; Cubellis, Mv
Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor
2019 Furlan, F; Eden, G; Archinti, M; Arnaudova, R; Andreotti, G; Citro, V; Cubellis, Mv; Motta, A; Degryse, B
Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidase
2018 Cimmaruta, C; Citro, V; Andreotti, G; Liguori, L; Cubellis, Mv; Hay Mele, B
D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo.
2018 Furlan, F; Eden, G; Archintia, M; Arnaudovaa, R; Andreotti, G; Citro, V; Cubellis, Mv; Motta, A; Degryse, B
E-learning for marine biotechnology: an example with a metagenomic approach
2018 Ludovica Liguori;Valentina Citro ; Bruno HayMele; Giuseppina Andreotti ;Maria Vittoria Cubellis
Passenger mutations as a target for the personalized therapy of cancer
2018 Maria Monticelli; ; Marcello Viscovo ; Guglielmo Riccio; Giuseppina Andreotti ;Bruno HayMele;Maria Vittoria Cubellis
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat | 1-gen-2024 | Hay Mele, Bruno; Rossetti, Federica; Cubellis, Maria Vittoria; Monticelli, Maria; Andreotti, Giuseppina | |
| Exploring ligand interactions with human phosphomannomutases using recombinant bacterial thermal shift assay and biochemical validation | 1-gen-2024 | Monticelli, Maria; Hay Mele, Bruno; Wright, Demi Marie; Guerriero, Simone; Andreotti, Giuseppina; Cubellis, Maria Vittoria | |
| ReBaTSA: A simplified CeTSA protocol for studying recombinant mutant proteins in bacterial extracts | 1-gen-2024 | Monticelli, Maria; Wright, Demi Marie; Cubellis, Maria Vittoria; Andreotti, Giuseppina | |
| Congenital disorders of glycosylation: narration of a story through its patents | 1-gen-2023 | Monticelli, Maria; D'Onofrio, Tania; Jaeken, Jaak; Morava, Eva; Andreotti, Giuseppina; Vittoria Cubellis, Maria | |
| Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease | 1-gen-2023 | Monticelli, Maria; Hay Mele, Bruno; Allocca, Mariateresa; Liguori, Ludovica; Lukas, Jan; Monti Maria, Chiara; Morretta, Elva; Cubellis Maria, Vittoria; Andreotti, Giuseppina | |
| Enzyme Replacement Therapy for FABRY Disease: Possible Strategies to Improve Its Efficacy | 1-gen-2023 | Iacobucci, Ilaria; Hay Mele, Bruno; Cozzolino, Flora; Monaco, Vittoria; Cimmaruta, Chiara; Monti, Maria; Andreotti, Giuseppina; Monticelli, Maria | |
| Drug Repositioning for Fabry Disease:Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones | 1-gen-2022 | Monticelli, M; Liguori, L; Allocca, M; Bosso, A; Andreotti, G; Lukas, J; Monti, Mc; Morretta, E; Cubellis, Mv; Mele, Bh | |
| Evolutionary rescue of phosphomannomutase deficiency in yeast models of human disease | 1-gen-2022 | C Vignogna, Ryan; Allocca, Mariateresa; Monticelli, Maria; W Norris, Joy; Steet, Richard; O Perlstein, Ethan; Andreotti, Giuseppina; I Lang, Gregory | |
| Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG) | 1-gen-2022 | Brasil, Sandra; Allocca, Mariateresa; M Magrinho, Salvador C; Santos, Inês; Raposo, Madalena; Francisco, Rita; Pascoal, Carlota; Martins, Tiago; A Videira, Paula; Pereira, Florbela; Andreotti, Giuseppina; Jaeken, Jaak; A Kantautas, Kristin; O Perlstein, Ethan; dos Reis Ferreira, Vanessa | |
| Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women | 1-gen-2021 | Monticelli, M; Hay Mele, B; Benetti, E; Fallerini, C; Baldassarri, M; Furini, S; Frullanti, E; Mari, F; GENCOVID Multicenter, Study; Andreotti, G; Cubellis, Mv; Renieri, A | |
| Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19 | 1-gen-2021 | Monticelli, M; Mele, Bh; Andreotti, G; Cubellis, Mv; Riccio, G | |
| Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations | 1-gen-2020 | Liguori, L; Monticelli, M; Allocca, M; Hay Mele, B; Lukas, J; Cubellis, Mv; Andreotti, G | |
| Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypesin Fabry disease | 1-gen-2020 | Seemann, Susanne; Ernst, Mathias; Cimmaruta, Chiara; Struckmann, Stephan; Cozma, Claudia; Koczan, Dirk; Knospe, Annemarie; R Haake, Linda; Citro, Valentina; U Bräuer, Anja; Andreotti, Giuseppina; V Cubellis, Maria; Fuellen, Georg; Hermann, Andreas; Giese, Annekatrin; Rolfs, Arndt; Lukas, Jan | |
| Rational Design, Synthesis, Characterization and Evaluation of Iodinated 4,4'-Bipyridines as New Transthyretin Fibrillogenesis Inhibitors | 1-gen-2020 | Dessì, Alessandro; Peluso, Paola; Dallocchio, Roberto; Weiss, Robin; Andreotti, Giuseppina; Allocca, Mariateresa; Aubert, Emmanuel; Pale, Patrick; Mamane, Victor; Cossu, Sergio | |
| ?-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG | 1-gen-2019 | Monticelli, M; Liguori, L; Allocca, M; Andreotti, G; Cubellis, Mv | |
| Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor | 1-gen-2019 | Furlan, F; Eden, G; Archinti, M; Arnaudova, R; Andreotti, G; Citro, V; Cubellis, Mv; Motta, A; Degryse, B | |
| Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidase | 1-gen-2018 | Cimmaruta, C; Citro, V; Andreotti, G; Liguori, L; Cubellis, Mv; Hay Mele, B | |
| D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo. | 1-gen-2018 | Furlan, F; Eden, G; Archintia, M; Arnaudovaa, R; Andreotti, G; Citro, V; Cubellis, Mv; Motta, A; Degryse, B | |
| E-learning for marine biotechnology: an example with a metagenomic approach | 1-gen-2018 | Ludovica Liguori;Valentina Citro ; Bruno HayMele; Giuseppina Andreotti ;Maria Vittoria Cubellis | |
| Passenger mutations as a target for the personalized therapy of cancer | 1-gen-2018 | Maria Monticelli; ; Marcello Viscovo ; Guglielmo Riccio; Giuseppina Andreotti ;Bruno HayMele;Maria Vittoria Cubellis |